The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 03, 2024
Filed:
Apr. 12, 2017
Applicant:
Tonix Pharma Limited, Dublin, IE;
Inventors:
Dean Carson, Palo Alto, CA (US);
David C. Yeomans, Sunnyvale, CA (US);
Assignee:
TONIX PHARMA LIMITED, Dublin, IE;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/095 (2019.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/194 (2006.01); A61K 33/06 (2006.01); A61K 33/14 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61M 15/00 (2006.01); A61M 15/08 (2006.01); A61P 25/00 (2006.01); A61P 25/22 (2006.01);
U.S. Cl.
CPC ...
A61K 38/095 (2019.01); A61K 9/0043 (2013.01); A61K 9/0048 (2013.01); A61K 9/006 (2013.01); A61K 9/0073 (2013.01); A61K 9/08 (2013.01); A61K 31/194 (2013.01); A61K 33/06 (2013.01); A61K 33/14 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61M 15/009 (2013.01); A61M 15/08 (2013.01); A61P 25/00 (2018.01); A61P 25/22 (2018.01);
Abstract
Disclosed are methods and compositions for the treatment of autism spectrum disorder, related disorders and symptoms of such disorders, comprising co-administration of an oxytocin peptide and magnesium ions. Co-administration of an oxytocin peptide and magnesium ions results in a synergistic or enhanced effect on reducing social and communication deficits in a patient suffering from an autism spectrum disorder.